Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 217 to 224 of 224 entries
Sorted by: Best Match Show Resources per page
Feasibility of micropollutants removal by solar-activated persulfate: Reactive oxygen species formation and influence on DBPs.

Water research

Tan C, Zhao H, Wang X, Yu H, Chong S, Xu Y, Du E, Chen M, Peng X, Su L.
PMID: 34952455
Water Res. 2021 Dec 19;210:117981. doi: 10.1016/j.watres.2021.117981. Epub 2021 Dec 19.

As a natural source of visible light and a type of renewable energy, solar energy is extensively used in the field of photochemistry. In this study, solar was employed to activate persulfate (PS) to degrade typical micropollutants. The removal...

Cite
Tan C, Zhao H, Wang X, et al. Feasibility of micropollutants removal by solar-activated persulfate: Reactive oxygen species formation and influence on DBPs. Water Res. 2021;210:117981doi: 10.1016/j.watres.2021.117981.
Tan, C., Zhao, H., Wang, X., Yu, H., Chong, S., Xu, Y., Du, E., Chen, M., Peng, X., & Su, L. (2021). Feasibility of micropollutants removal by solar-activated persulfate: Reactive oxygen species formation and influence on DBPs. Water research, 210117981. https://doi.org/10.1016/j.watres.2021.117981
Tan, Chaoqun, et al. "Feasibility of micropollutants removal by solar-activated persulfate: Reactive oxygen species formation and influence on DBPs." Water research vol. 210 (2021): 117981. doi: https://doi.org/10.1016/j.watres.2021.117981
Tan C, Zhao H, Wang X, Yu H, Chong S, Xu Y, Du E, Chen M, Peng X, Su L. Feasibility of micropollutants removal by solar-activated persulfate: Reactive oxygen species formation and influence on DBPs. Water Res. 2021 Dec 19;210:117981. doi: 10.1016/j.watres.2021.117981. Epub 2021 Dec 19. PMID: 34952455.
Copy Download .nbib Format: NLM
Surfactant free synthesis of cationic nano-vesicles: A safe triple drug loaded vehicle for the topical treatment of cutaneous leishmaniasis.

Nanomedicine : nanotechnology, biology, and medicine

Khalid S, Salman S, Iqbal K, Rehman FU, Ullah I, Satoskar AR, Khan GM, Dar MJ.
PMID: 34748957
Nanomedicine. 2021 Nov 05;40:102490. doi: 10.1016/j.nano.2021.102490. Epub 2021 Nov 05.

The basic aim of the study was to develop and evaluate the triple drug loaded cationic nano-vesicles (cNVs), where miltefosine was used as a replacement of surfactant (apart from its anti-leishmanial role), in addition to meglumine antimoniate (MAM) and...

Cite
Khalid S, Salman S, Iqbal K, et al. Surfactant free synthesis of cationic nano-vesicles: A safe triple drug loaded vehicle for the topical treatment of cutaneous leishmaniasis. Nanomedicine. 2021;40:102490doi: 10.1016/j.nano.2021.102490.
Khalid, S., Salman, S., Iqbal, K., Rehman, F. U., Ullah, I., Satoskar, A. R., Khan, G. M., & Dar, M. J. (2021). Surfactant free synthesis of cationic nano-vesicles: A safe triple drug loaded vehicle for the topical treatment of cutaneous leishmaniasis. Nanomedicine : nanotechnology, biology, and medicine, 40102490. https://doi.org/10.1016/j.nano.2021.102490
Khalid, Sidra, et al. "Surfactant free synthesis of cationic nano-vesicles: A safe triple drug loaded vehicle for the topical treatment of cutaneous leishmaniasis." Nanomedicine : nanotechnology, biology, and medicine vol. 40 (2021): 102490. doi: https://doi.org/10.1016/j.nano.2021.102490
Khalid S, Salman S, Iqbal K, Rehman FU, Ullah I, Satoskar AR, Khan GM, Dar MJ. Surfactant free synthesis of cationic nano-vesicles: A safe triple drug loaded vehicle for the topical treatment of cutaneous leishmaniasis. Nanomedicine. 2021 Nov 05;40:102490. doi: 10.1016/j.nano.2021.102490. Epub 2021 Nov 05. PMID: 34748957.
Copy Download .nbib Format: NLM
Combination of topical liposomal amphotericin B and Glucantime in comparison with glucantime alone for the treatment of anthroponotic cutaneous leishmaniasis (ACL) caused by .

Iranian journal of microbiology

Eskandari SE, Khamesipour A, Jaafari MR, Javadi A, Mohammadi AM, Valian HK, Nassiri-Kashani M, Goyonlo VM, Firooz A.
PMID: 34900170
Iran J Microbiol. 2021 Oct;13(5):718-723. doi: 10.18502/ijm.v13i5.7440.

BACKGROUND AND OBJECTIVES: Cutaneous leishmaniasis (CL) treatment is a challenging issue, although numerous modalities have been introduced as candidate treatment for CL yet only antimonial agents are commonly used to treat CL, a different form of amphotericin B is...

Cite
Eskandari SE, Khamesipour A, Jaafari MR, et al. Combination of topical liposomal amphotericin B and Glucantime in comparison with glucantime alone for the treatment of anthroponotic cutaneous leishmaniasis (ACL) caused by . Iran J Microbiol. 2021;13(5):718-723doi: 10.18502/ijm.v13i5.7440.
Eskandari, S. E., Khamesipour, A., Jaafari, M. R., Javadi, A., Mohammadi, A. M., Valian, H. K., Nassiri-Kashani, M., Goyonlo, V. M., & Firooz, A. (2021). Combination of topical liposomal amphotericin B and Glucantime in comparison with glucantime alone for the treatment of anthroponotic cutaneous leishmaniasis (ACL) caused by . Iranian journal of microbiology, 13(5), 718-723. https://doi.org/10.18502/ijm.v13i5.7440
Eskandari, Seyed Ebrahim, et al. "Combination of topical liposomal amphotericin B and Glucantime in comparison with glucantime alone for the treatment of anthroponotic cutaneous leishmaniasis (ACL) caused by ." Iranian journal of microbiology vol. 13,5 (2021): 718-723. doi: https://doi.org/10.18502/ijm.v13i5.7440
Eskandari SE, Khamesipour A, Jaafari MR, Javadi A, Mohammadi AM, Valian HK, Nassiri-Kashani M, Goyonlo VM, Firooz A. Combination of topical liposomal amphotericin B and Glucantime in comparison with glucantime alone for the treatment of anthroponotic cutaneous leishmaniasis (ACL) caused by . Iran J Microbiol. 2021 Oct;13(5):718-723. doi: 10.18502/ijm.v13i5.7440. PMID: 34900170; PMCID: PMC8629814.
Copy Download .nbib Format: NLM
Physicians with self-diagnosed gadolinium deposition disease: a case series.

Radiologia brasileira

Semelka RC, Ramalho M.
PMID: 34393290
Radiol Bras. 2021 Jul-Aug;54(4):238-242. doi: 10.1590/0100-3984.2020.0073.

OBJECTIVE: The objective of this study was to allow physicians with self-diagnosed gadolinium deposition disease symptoms to report their own experience.MATERIALS AND METHODS: Nine physicians (seven females), with a mean age of 50.5 ± 8.3 years, participated in this...

Cite
Semelka RC, Ramalho M. Physicians with self-diagnosed gadolinium deposition disease: a case series. Radiol Bras. 2021;54(4):238-242doi: 10.1590/0100-3984.2020.0073.
Semelka, R. C., & Ramalho, M. (2021). Physicians with self-diagnosed gadolinium deposition disease: a case series. Radiologia brasileira, 54(4), 238-242. https://doi.org/10.1590/0100-3984.2020.0073
Semelka, Richard C, and Ramalho, Miguel. "Physicians with self-diagnosed gadolinium deposition disease: a case series." Radiologia brasileira vol. 54,4 (2021): 238-242. doi: https://doi.org/10.1590/0100-3984.2020.0073
Semelka RC, Ramalho M. Physicians with self-diagnosed gadolinium deposition disease: a case series. Radiol Bras. 2021 Jul-Aug;54(4):238-242. doi: 10.1590/0100-3984.2020.0073. PMID: 34393290; PMCID: PMC8354197.
Copy Download .nbib Format: NLM
New onset of sinoatrial block in a young patient treated with systemic meglumine antimoniate.

Clinical case reports

Daadaa N, Youssef S, Haggui A, Harbaoui S, Jaber K, Doss N, Dhaoui MR.
PMID: 33768944
Clin Case Rep. 2021 Jan 16;9(3):1797-1798. doi: 10.1002/ccr3.3768. eCollection 2021 Mar.

The sinoatrial block is a new side effect of meglumine antimoniate. Prompt interruption of the drug results in the normalization of electrographic changes and prevents sudden cardiac arrest.

Cite
Daadaa N, Youssef S, Haggui A, et al. New onset of sinoatrial block in a young patient treated with systemic meglumine antimoniate. Clin Case Rep. 2021;9(3):1797-1798doi: 10.1002/ccr3.3768.
Daadaa, N., Youssef, S., Haggui, A., Harbaoui, S., Jaber, K., Doss, N., & Dhaoui, M. R. (2021). New onset of sinoatrial block in a young patient treated with systemic meglumine antimoniate. Clinical case reports, 9(3), 1797-1798. https://doi.org/10.1002/ccr3.3768
Daadaa, Najla, et al. "New onset of sinoatrial block in a young patient treated with systemic meglumine antimoniate." Clinical case reports vol. 9,3 (2021): 1797-1798. doi: https://doi.org/10.1002/ccr3.3768
Daadaa N, Youssef S, Haggui A, Harbaoui S, Jaber K, Doss N, Dhaoui MR. New onset of sinoatrial block in a young patient treated with systemic meglumine antimoniate. Clin Case Rep. 2021 Jan 16;9(3):1797-1798. doi: 10.1002/ccr3.3768. eCollection 2021 Mar. PMID: 33768944; PMCID: PMC7981715.
Copy Download .nbib Format: NLM
Effect of flunixin meglumine treatment during and after embryo transfer on the pregnancy rate in cattle.

Reproduction in domestic animals = Zuchthygiene

Karasahin T, Alkan H, Satilmis F, Dursun S, Erdem H.
PMID: 34523163
Reprod Domest Anim. 2021 Dec;56(12):1555-1561. doi: 10.1111/rda.14019. Epub 2021 Sep 17.

This study aimed to determine the effect of flunixin meglumine treatment during and after the transfer of in vivo produced embryos to Angus (cows) and Holstein (cows and heifers) breeds of cattle on pregnancy rate. Holstein cows were used...

Cite
Karasahin T, Alkan H, Satilmis F, et al. Effect of flunixin meglumine treatment during and after embryo transfer on the pregnancy rate in cattle. Reprod Domest Anim. 2021;56(12):1555-1561doi: 10.1111/rda.14019.
Karasahin, T., Alkan, H., Satilmis, F., Dursun, S., & Erdem, H. (2021). Effect of flunixin meglumine treatment during and after embryo transfer on the pregnancy rate in cattle. Reproduction in domestic animals = Zuchthygiene, 56(12), 1555-1561. https://doi.org/10.1111/rda.14019
Karasahin, Tahir, et al. "Effect of flunixin meglumine treatment during and after embryo transfer on the pregnancy rate in cattle." Reproduction in domestic animals = Zuchthygiene vol. 56,12 (2021): 1555-1561. doi: https://doi.org/10.1111/rda.14019
Karasahin T, Alkan H, Satilmis F, Dursun S, Erdem H. Effect of flunixin meglumine treatment during and after embryo transfer on the pregnancy rate in cattle. Reprod Domest Anim. 2021 Dec;56(12):1555-1561. doi: 10.1111/rda.14019. Epub 2021 Sep 17. PMID: 34523163.
Copy Download .nbib Format: NLM
Can Deep Learning Replace Gadolinium in Neuro-Oncology?: A Reader Study.

Investigative radiology

Ammari S, Bône A, Balleyguier C, Moulton E, Chouzenoux É, Volk A, Menu Y, Bidault F, Nicolas F, Robert P, Rohé MM, Lassau N.
PMID: 34324463
Invest Radiol. 2021 Jul 28; doi: 10.1097/RLI.0000000000000811. Epub 2021 Jul 28.

This study proposes and evaluates a deep learning method that predicts surrogate images for contrast-enhanced T1 from multiparametric magnetic resonance imaging (MRI) acquired using only a quarter of the standard 0.1 mmol/kg dose of gadolinium-based contrast agent. In particular,...

Cite
Ammari S, Bône A, Balleyguier C, et al. Can Deep Learning Replace Gadolinium in Neuro-Oncology?: A Reader Study. Invest Radiol. 2021;doi: 10.1097/RLI.0000000000000811.
Ammari, S., Bône, A., Balleyguier, C., Moulton, E., Chouzenoux, �. �., Volk, A., Menu, Y., Bidault, F., Nicolas, F., Robert, P., Rohé, M. M., & Lassau, N. (2021). Can Deep Learning Replace Gadolinium in Neuro-Oncology?: A Reader Study. Investigative radiology, . https://doi.org/10.1097/RLI.0000000000000811
Ammari, Samy, et al. "Can Deep Learning Replace Gadolinium in Neuro-Oncology?: A Reader Study." Investigative radiology vol. (2021). doi: https://doi.org/10.1097/RLI.0000000000000811
Ammari S, Bône A, Balleyguier C, Moulton E, Chouzenoux É, Volk A, Menu Y, Bidault F, Nicolas F, Robert P, Rohé MM, Lassau N. Can Deep Learning Replace Gadolinium in Neuro-Oncology?: A Reader Study. Invest Radiol. 2021 Jul 28; doi: 10.1097/RLI.0000000000000811. Epub 2021 Jul 28. PMID: 34324463.
Copy Download .nbib Format: NLM
The Emergence of Co-Infection of Visceral Leishmaniasis in an Iranian Child with Chronic Granulomatous Disease: A Case Report.

Iranian journal of parasitology

Abdolsalehi MR, Mohebali M, Keshavarz H, Mahmoudi S, Mamishi S.
PMID: 33786058
Iran J Parasitol. 2021 Jan-Mar;16(1):159-163. doi: 10.18502/ijpa.v16i1.5536.

Chronic granulomatous disease (CGD) described as an essential immunodeficiency problem of phagocytic cells resulting in a phagocyte dysfunction and inability to kill a spectrum of bacteria and fungi. Despite the fact that CGD patients are more susceptible to intracellular...

Cite
Abdolsalehi MR, Mohebali M, Keshavarz H, et al. The Emergence of Co-Infection of Visceral Leishmaniasis in an Iranian Child with Chronic Granulomatous Disease: A Case Report. Iran J Parasitol. 2021;16(1):159-163doi: 10.18502/ijpa.v16i1.5536.
Abdolsalehi, M. R., Mohebali, M., Keshavarz, H., Mahmoudi, S., & Mamishi, S. (2021). The Emergence of Co-Infection of Visceral Leishmaniasis in an Iranian Child with Chronic Granulomatous Disease: A Case Report. Iranian journal of parasitology, 16(1), 159-163. https://doi.org/10.18502/ijpa.v16i1.5536
Abdolsalehi, Mohammad Reza, et al. "The Emergence of Co-Infection of Visceral Leishmaniasis in an Iranian Child with Chronic Granulomatous Disease: A Case Report." Iranian journal of parasitology vol. 16,1 (2021): 159-163. doi: https://doi.org/10.18502/ijpa.v16i1.5536
Abdolsalehi MR, Mohebali M, Keshavarz H, Mahmoudi S, Mamishi S. The Emergence of Co-Infection of Visceral Leishmaniasis in an Iranian Child with Chronic Granulomatous Disease: A Case Report. Iran J Parasitol. 2021 Jan-Mar;16(1):159-163. doi: 10.18502/ijpa.v16i1.5536. PMID: 33786058; PMCID: PMC7988672.
Copy Download .nbib Format: NLM
Showing 217 to 224 of 224 entries